Biosig Technologies (BSGM)

Nov 13, 2024, 3:14 PM EST - 2 months ago

BioSig Regains Compliance with Nasdaq's Minimum Bid Price Requirement

Oct 22, 2024, 3:13 PM EDT - 3 months ago

BioSig Technologies' Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel

Jul 31, 2024, 9:45 AM EDT - 6 months ago

BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation

Jul 25, 2024, 1:57 PM EDT - 6 months ago

BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024

Jun 10, 2024, 9:45 AM EDT - 7 months ago

BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer

May 30, 2024, 4:05 PM EDT - 8 months ago

BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

May 21, 2024, 11:10 AM EDT - 8 months ago

BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders

May 3, 2024, 12:22 PM EDT - 9 months ago

BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent

Apr 30, 2024, 2:03 PM EDT - 9 months ago

BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately

Apr 4, 2024, 11:35 AM EDT - 10 months ago

BioSig Engages Consulting Firm for Business Model Strategies

Feb 20, 2024, 10:00 AM EST - 11 months ago

BioSig Announces Reduction of its Workforce

Feb 6, 2024, 8:30 AM EST - 1 year ago

BioSig's PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases

Jan 31, 2024, 11:15 AM EST - 1 year ago

BioSig Announces Reverse Stock Split

Jan 30, 2024, 8:30 AM EST - 1 year ago

BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy

Dec 6, 2023, 2:20 PM EST - 1 year ago

BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024

Nov 13, 2023, 4:30 PM EST - 1 year ago

BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 1, 2023, 8:30 AM EDT - 1 year ago

BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio Covering Digital Signal Processing Technology and AI

Aug 24, 2023, 10:30 AM EDT - 1 year ago

BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals

Aug 23, 2023, 8:30 AM EDT - 1 year ago

BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations

Aug 22, 2023, 8:00 AM EDT - 1 year ago

BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient Cases

Jul 25, 2023, 8:30 AM EDT - 1 year ago

BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications

Jul 20, 2023, 7:11 AM EDT - 1 year ago

BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals

Jun 29, 2023, 8:30 AM EDT - 1 year ago

BioSig Joins Webull Corporate Connect

Jun 27, 2023, 8:30 AM EDT - 1 year ago

BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare

May 25, 2023, 9:00 AM EDT - 1 year ago

New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market

May 19, 2023, 7:30 AM EDT - 1 year ago

New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias

Mar 27, 2023, 8:38 AM EDT - 1 year ago

BioSig Announces New Advisory Board Member Edwin Wang

Mar 24, 2023, 8:30 AM EDT - 1 year ago

BioSig Announces New Advisory Board Member Lorraine Spurge

Mar 13, 2023, 7:30 AM EDT - 2 years ago

BioSig Confirms No Exposure to Silicon Valley Bank

Feb 22, 2023, 7:30 AM EST - 2 years ago

BioSig Regains Compliance With All Nasdaq Listing Standards

Feb 17, 2023, 7:30 AM EST - 2 years ago

BioSig Awarded US Patent Claims for its Universal Notch Filter Technology

Feb 7, 2023, 8:00 AM EST - 2 years ago

BioSig Appoints Former Qorvo CFO as Successor to Steve Chaussy

Jan 10, 2023, 8:30 AM EST - 2 years ago

BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology

Dec 14, 2022, 4:30 PM EST - 2 years ago

Update: BioSig's PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore

Dec 14, 2022, 8:00 AM EST - 2 years ago

BioSig's PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore

Dec 6, 2022, 8:30 AM EST - 2 years ago

BioSig's PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology

Oct 24, 2022, 11:03 AM EDT - 2 years ago

BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology

Oct 12, 2022, 10:00 AM EDT - 2 years ago

BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022

Oct 7, 2022, 9:35 AM EDT - 2 years ago

BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base

Sep 22, 2022, 9:00 AM EDT - 2 years ago

BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module

Sep 8, 2022, 9:33 AM EDT - 2 years ago

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

BJDX STSS

Sep 6, 2022, 10:58 AM EDT - 2 years ago

(BSGM), (OPFI) – 3 Stocks Under $3 Insiders Are Buying

OPFI

Sep 1, 2022, 9:21 AM EDT - 2 years ago

(BSGM), (LDI) – BioSig Technologies, Reliance Global Group And 2 Other Penny Stocks Insiders Are Aggressively Buying

LDI OPFI RELI

Aug 30, 2022, 9:37 AM EDT - 2 years ago

BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth

Aug 24, 2022, 9:17 AM EDT - 2 years ago

BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence

Aug 17, 2022, 9:15 AM EDT - 2 years ago

BioSig's Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022

Aug 16, 2022, 9:47 AM EDT - 2 years ago

BioSig Sees Positive Momentum from Sales Pipeline Growth

Jul 21, 2022, 10:00 AM EDT - 2 years ago

BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute

Jul 7, 2022, 8:30 AM EDT - 2 years ago

BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center

Jun 29, 2022, 5:45 PM EDT - 2 years ago

BioSig Announces Closing of Public Offering of Common Stock